Preliminary results of the Phase II study of clofarabine in refractory relapse leukemia.
| Disease . | No. Evaluable . | No. CR + CRp (%) . |
|---|---|---|
| Abbreviations: AML, acute myeloid leukemia; ALL, acute lymphocytic leukemia; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; CR, complete remission; CRp, CR with low platelets. | ||
| AML | 20 | 11 + 1 (60) |
| ALL | 6 | 1 + 1 (33) |
| CML-blastic phase | 6 | 3 + 1 (67) |
| MDS/CML | 4 | 1 + 2 (75) |
| Disease . | No. Evaluable . | No. CR + CRp (%) . |
|---|---|---|
| Abbreviations: AML, acute myeloid leukemia; ALL, acute lymphocytic leukemia; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; CR, complete remission; CRp, CR with low platelets. | ||
| AML | 20 | 11 + 1 (60) |
| ALL | 6 | 1 + 1 (33) |
| CML-blastic phase | 6 | 3 + 1 (67) |
| MDS/CML | 4 | 1 + 2 (75) |